Anti-tumor effect of Cordyceps militaris in HCV-infected human hepatocarcinoma 7.5 cells

Journal of Microbiology

Volumn 53, Issue 7, 2015, Pages 468-474

  Lee, Seulki ^a   Lee, Hwan Hee ^a   Kim, Jisung ^a   Jung, Joohee ^a   Moon, Aree ^a   Jeong, Choon Sik ^a   Kang, Hyojeung ^b   Cho, Hyosun ^a  

^a Duksung Women's University   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

apoptosis; Bax; Cordyceps militaris; HCV; human hepatocarcinoma 7.5 cells; PARP

Indexed keywords

CORDYCEPS; CORDYCEPS MILITARIS; HEPATITIS C VIRUS;

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; NS3 PROTEIN, HEPATITIS C VIRUS; PROTEIN BAX; PROTEIN P53; TP53 PROTEIN, HUMAN; VIRUS PROTEIN;

ANIMAL; ANTIBIOSIS; APOPTOSIS; BAGG ALBINO MOUSE; CHEMISTRY; CORDYCEPS; DRUG SCREENING; HEPACIVIRUS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIBIOSIS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CORDYCEPS; HEPACIVIRUS; HUMANS; MICE, INBRED BALB C; TUMOR SUPPRESSOR PROTEIN P53; VIRAL NONSTRUCTURAL PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84932600690     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-015-5198-x     Document Type: Article

References (35)

1. Adrain C., Slee E.A., Harte M.T., and Martin S.J. 1999. Regulation of apoptotic protease activating factor-1 oligomerization and apoptosis by the wd-40 repeat region. J. Biol. Chem.274, 20855–20860.
2. Ahn S., Hyeon J., and Park C.K. 2013. Metadherin is a prognostic predictor of hepatocellular carcinoma after curative hepatectomy. Gut Liver7, 206–212.
3. Binder M., Kochs G., Bartenschlager R., and Lohmann V. 2007. Hepatitis c virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology46, 1365–1374.
4. Blight K.J., McKeating J.A., and Rice C.M. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis c virus RNA replication. J. Virol.76, 13001–13014.
5. Boulares A.H., Yakovlev A.G., Ivanova V., Stoica B.A., Wang G., Iyer S., and Smulson M. 1999. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J. Biol. Chem.274, 22932–22940.
6. Cain K., Brown D.G., Langlais C., and Cohen G.M. 1999. Caspase activation involves the formation of the aposome, a large (approximately 700 kDa) caspase-activating complex. J. Biol. Chem.274, 22686–22692.
7. El-Serag H.B. and Rudolph K.L. 2007. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology132, 2557–2576.
8. Kim S.P., Nam S.H., and Friedman M. 2013. Hericium erinaceus (Lion’s Mane) mushroom extracts inhibit metastasis of cancer cells to the lung in CT-26 colon cancer-tansplanted mice. J. Agric. Food Chem.61, 4898–4904.
9. Kim B.S. and Park Y.M. 1993. Prevalence of hepatitis C virus related to liver diseases in Korea. Gastroenterologia Japonica28 Suppl 5, 17–22.
10. Kunjadia P.D., Nagee A., Pandya P.Y., Mukhopadhyaya P.N., Sanghvi G.V., and Dave G.S. 2014. Medicinal and antimicrobial role of the oyster culinary-medicinal mushroom Pleurotus ostreatus (higher Basidiomycetes) cultivated on banana agrowastes in India. Int. J. Med. Mushrooms16, 227–238.
11. Lakin N.D. and Jackson S.P. 1999. Regulation of p53 in response to DNA damage. Oncogene18, 7644–7655.
12. Lauer G.M. and Walker B.D. 2001. Hepatitis c virus infection. N Eng. J. Med.345, 41–52.
13. Lee H.H., Jeong J.W., Lee J.H., Kim G.Y., Cheong J., Jeong Y.K., Yoo Y.H., and Choi Y.H. 2013. Cordycepin increases sensitivity of Hep3B human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by inactivating the JNK signaling pathway. Oncol. Rep.30, 1257–1264.
14. Lee H., Kim Y.J., Kim H.W., Lee D.H., Sung M.K., and Park T. 2006. Induction of apoptosis by Cordyceps militaris through activation of caspase-3 in leukemia HL-60 cells. Biol. Pharm. Bull.29, 670–674.
15. Lee H.H., Park H., Sung G.H., Lee K., Lee T., Lee I., Park M.S., Jung Y.W., Shin Y.S., Kang H., et al. 2014. Anti-influenza effect of Cordyceps militaris through immunomodulation in a DBA/2 mouse model. J. Microbiol.52, 696–701.
16. Liang T.J., Rehermann B., Seeff L.B., and Hoofnagle J.H. 2000. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med.132, 296–305.
17. Ling C.Q., Yue X.Q., and Ling C. 2014. Three advantages of using traditional Chinese medicine to prevent and treat tumor. J. Integr. Med.12, 331–335.
18. Lu H., Li X., Zhang J., Shi H., Zhu X., and He X. 2014. Effects of cordycepin on HepG2 and EA.hy926 cells: Potential antiproliferative, antimetastatic and anti-angiogenic effects on hepatocellular carcinoma. Oncol. Lett.7, 1556–1562.
19. Maluccio M. and Covey A. 2012. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J. Clin.62, 394–399.
20. Murphy K.M., Ranganathan V., Farnsworth M.L., Kavallaris M., and Lock R.B. 2000. Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ. 7, 102–111.
21. Nakabayashi H., Taketa K., Miyano K., Yamane T., and Sato J. 1982. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res.42, 3858–3863.
22. Park C., Hong S.H., Lee J.Y., Kim G.Y., Choi B.T., Lee Y.T., Park D.I., Park Y.M., Jeong Y.K., and Choi Y.H. 2005. Growth inhibition of U937 leukemia cells by aqueous extract of Cordyceps militaris through induction of apoptosis. Oncol. Rep.13, 1211–1216.
23. Son M., Lee M., Ryu E., Moon A., Jeong C.S., Jung Y.W., Park G.H., Sung G.H., Cho H., and Kang H. 2015. Genipin as a novel chemical activator of EBV lytic cycle. J. Microbiol.53, 155–165.
24. Sun Y.S., Lv L.X., Zhao Z., He X., You L., Liu J.K., and Li Y.Q. 2014. Cordycepol C induces caspase-independent apoptosis in human hepatocellular carcinoma HepG2 cells. Biol. Pharm. Bull.37, 608–617.
25. Tuli H.S., Sharma A.K., Sandhu S.S., and Kashyap D. 2013. Cordycepin: A bioactive metabolite with therapeutic potential. Life Sci.93, 863–869.
26. Ueda Y., Mori K., Satoh S., Dansako H., Ikeda M., and Kato N. 2014. Anti-HCV activity of the Chinese medicinal fungus Cordyceps militaris. Biochem. Biophys. Res. Commun.447, 341–345.
27. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., et al. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med.11, 791–796.
28. Wang B.J., Won S.J., Yu Z.R., and Su C.L. 2005. Free radical scavenging and apoptotic effects of Cordyceps sinensis fractionated by supercritical carbon dioxide. Food Chem. Toxicol.43, 543–552.
29. Wang H., Zhang J., Sit W.H., Lee C.Y., and Wan J.M. 2014. Cordyceps cicadae induces G2/M cell cycle arrest in MHCC97H human hepatocellular carcinoma cells: A proteomic study. Chin. Med.9, 15.
30. Wu X. and Deng Y. 2002. Bax and BH3-domain-only proteins in p53-mediated apoptosis. Front. Biosci.7, d151–156.
31. Yang Y., Hu J., Liu Y., Feng N., Chen H., Tang Q., Ye L., and Zhang J. 2011. Antioxidant and cytotoxic activities of ethanolic extracts and isolated fractions of species of the genus Phellinus Quél. (Aphyllophoromycetideae). Int. J. Med. Mushrooms13, 145–152.
32. Yue K., Ye M., Zhou Z., Sun W., and Lin X. 2013. The genus Cordyceps: A chemical and pharmacological review. J. Pharm. Pharmacol.65, 474–493.
33. Zhai X.F., Chen Z., Li B., Shen F., Fan J., Zhou W.P., Yang Y.K., Xu J., Qin X., Li L.Q., et al. 2013. Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: A multicenter randomized controlled trial. J. Integr. Med.11, 90–100.
34. Zhang W., Li J., Qiu S., Chen J., and Zheng Y. 2008. Effects of the exopolysaccharide fraction (EPSF) from a cultivated Cordyceps sinensis on immunocytes of H22 tumor bearing mice. Fitoterapia79, 168–173.
35. Zhao Y.Y., Shen X., Chao X., Ho C.C., Cheng X.L., Zhang Y., Lin R.C., Du K.J., Luo W.J., Chen J.Y., et al. 2011. Ergosta-4,6, 8(14),22-tetraen-3-one induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Biochim. Biophys. Acta.1810, 384–390.